Dysphagia in multiple sclerosis - prevalence and prognostic factors

Acta Neurologica Scandinavica
P CalcagnoS Paolucci

Abstract

The aim of the study was to analyse swallowing function and to identify reliable prognostic factors associated with dysphagia in a consecutive series of patients with multiple sclerosis (MS). Swallowing examination was performed by means of indirect and direct methods (fiberendoscopic evaluation) in 143 consecutive patients with primary and secondary progressive MS. Dysphagia was found in 49 patients (34.3%). A close relationship with dysphagia was found in the patients with severe brainstem impairment (OR=3.24; 95% CI 1.44-7.31) as compared to the patients without. There was also a significant correlation with pronounced severity of illness (OR=2.99; CI 1.36-6.59). Compensatory strategies were sufficient to resolve the dysphagia in 46 cases (93.8%). The potential risk of aspiration and malnutrition and the high efficacy of swallowing rehabilitation suggests that all MS patients should have a careful evaluation of deglutition functionality, especially those with brainstem impairment and a high grade of disability level.

References

Aug 1, 1991·Neurology·A D SadovnickD W Paty
Jan 1, 1984·Brain, Behavior and Evolution·A Jean
Mar 1, 1983·Annals of Neurology·C M PoserW W Tourtellotte
Jan 1, 1994·Folia Phoniatrica Et Logopaedica : Official Organ of the International Association of Logopedics and Phoniatrics (IALP)·L Hartelius, P Svensson
Apr 1, 1995·Multiple Sclerosis : Clinical and Laboratory Research·J N WhitakerS C Reingold
Jul 8, 1999·Folia Phoniatrica Et Logopaedica : Official Organ of the International Association of Logopedics and Phoniatrics (IALP)·J A LogemannP J Kahrilas
Aug 25, 1999·Journal of Neurology·F J Thomas, C M Wiles

❮ Previous
Next ❯

Citations

Dec 18, 2008·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Cristina TassorelliGiuseppe Nappi
May 17, 2005·Physical Medicine and Rehabilitation Clinics of North America·Theodore R Brown, George H Kraft
May 3, 2007·Journal of Palliative Medicine·Lauren B ElmanLeo McCluskey
Apr 9, 2005·Journal of Clinical Gastroenterology·Sami R Achem, Kenneth R Devault
Aug 25, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D A RestivoA Pavone
Feb 22, 2003·BMJ : British Medical Journal·Paula LeslieJanet A Wilson
Oct 21, 2011·Neurology Research International·Fary KhanLynne Turner-Stokes
Sep 13, 2006·European Neurology·T HenzeUNKNOWN Multiple Sclerosis Therapy Consensus Group of the German Multiple Sclerosis Society
Jun 23, 2011·Therapeutic Advances in Neurological Disorders·João Carlos Correia de SaBernd C Kieseier
Nov 10, 2005·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Julia GatesGary D Gramigna
Jun 15, 2013·Multiple Sclerosis International·Sanober NusratKlaus Bielefeldt
Sep 26, 2014·Tijdschrift voor gerontologie en geriatrie·J G Kalf, S de Wit
Feb 18, 2011·Expert Opinion on Pharmacotherapy·Francesca BagnatoStefano Strano
Nov 23, 2013·Otolaryngologic Clinics of North America·Dylan F Roden, Kenneth W Altman
Nov 23, 2013·Otolaryngologic Clinics of North America·Kenneth W AltmanDaniel J McCabe
Oct 9, 2012·Brain Stimulation·Domenico A RestivoAntonino Pavone
Oct 23, 2008·Physical Medicine and Rehabilitation Clinics of North America·Marlís González-Fernández, Stephanie K Daniels
Feb 19, 2008·Journal of the Neurological Sciences·R BergamaschiV Cosi
Aug 10, 2013·Brazilian Journal of Otorhinolaryngology·Alessandro Murano Ferré FernandesCharles Peter Tilbery
Jul 24, 2015·Journal of the Neurological Sciences·Sasan AndalibAlbert Gjedde
Aug 20, 2014·International Journal of Language & Communication Disorders·Marta RenomMichaela Coenen
Apr 23, 2013·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·E AlfonsiA Moglia
Apr 8, 2015·Nature Reviews. Gastroenterology & Hepatology·Pere Clavé, Reza Shaker
Mar 11, 2011·Annals of Physical and Rehabilitation Medicine·S Demaille-WlodykaUNKNOWN ETP Sofmer Group
Mar 6, 2010·Multiple Sclerosis : Clinical and Laboratory Research·Marziyeh PoorjavadAmir-Hadi Maghzi
Jun 10, 2020·International Journal of Environmental Research and Public Health·Francesco CovelloIole Vozza
Mar 18, 2020·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A PrintzaN Grigoriadis
Nov 30, 2018·International Journal of Environmental Research and Public Health·Joanna Dymecka, Mariola Bidzan
Apr 16, 2010·The Annals of Otology, Rhinology, and Laryngology·Michael BroniatowskiDustin J Tyler
Jun 14, 2017·Multiple Sclerosis Journal - Experimental, Translational and Clinical·Erin Pearson SilvermanJanis J Daly
Feb 23, 2019·Expert Review of Gastroenterology & Hepatology·Emanuele D'AmicoSalvatore Cocuzza
Apr 11, 2020·Degenerative Neurological and Neuromuscular Disease·Noureddin Nakhostin AnsariLeila Ghelichi
May 18, 2018·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Athanasia PrintzaJannis Constantinidis
Dec 22, 2019·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·C SolaroM G Grasso
Feb 12, 2021·Fortschritte der Neurologie-Psychiatrie·Carolin EckardtMelanie Weinert
Feb 14, 2021·Dysphagia·Mahdi BarzegarVahid Shaygannejad
Mar 3, 2021·Multiple Sclerosis and Related Disorders·Déborah Santos SalesLuiz Claudio Santos Thuler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.